Feb 02, 2023
More than 10% of older adults develop somatic (non-inherited) mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells, increasing the risk for blood cancer and cardiovascular disease. Multiple DNA sequencing methods have been used to identify what is called “clonal hematopoiesis of indeterminate potential,” or CHIP, but it has been difficult to distinguish true mutations from artifacts.